Screening for Heart Failure Using a Multimodal Wearable Device - Trial NCT06335264
Access comprehensive clinical trial information for NCT06335264 through Pure Global AI's free database. This phase not specified trial is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre and is currently Recruiting. The study focuses on Heart Failure. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
McGill University Health Centre/Research Institute of the McGill University Health Centre
Timeline & Enrollment
N/A
Jan 15, 2024
Dec 01, 2024
Primary Outcome
Presence or absence of heart failure
Summary
The purpose of this study is to find out if there are any patterns in the way people's bodies
 react to physical activities and their voices when they have heart failure, a disease where
 the heart cannot function sufficiently. To do this, the investigators will use a smartwatch
 that can measure multiple signals like the participant's heart rate and movement.
 Investigators will ask participants with and without heart failure to wear the Watch HOP
 (from HOP-Child Technologies Inc.) and sensors during physical tasks at their clinic visit at
 the McGill University Health Centre. Researchers will also record the participants' voices
 between their visits. The key signals can help find who is at risk for heart failure or
 develop new ways to monitor and treat it.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06335264
Device Trial